The National Business Review20m
AFT’s Maxigesic IV to be made and sold in China
Maxigesic IV will now be sold in nine of the 10 largest pharma markets in the world. Dual-listed AFT Pharmaceuticals has ...
The National Business Review23m
Working from home: no entitlement, plenty of expectation
According to Eaqub and Statistics New Zealand figures, about 25% of workers work from home some of the time, ...
The National Business Review23m
Podcast #16: Kiwi music legend Brent Eccles turns 70
In this episode of The NBR Podcast with Simon Shepherd: As he turns 70, music promoter Brent Eccles reveals why concert ...
The National Business Review45m
Kami majority stake sale to BV receives OIO approval
The National Business Review Online is New Zealand's authority in breaking business news and analysis.
The National Business Review48m
Being AI extends Spectrum buy timeline and share offer period
Exclusive offer for uni students studying at a New Zealand university (valued at $499).